Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide, sold in the UK as Mounjaro, is supplied as a ready-to-inject pre-filled KwikPen — no mixing, no reconstitution, no vials required. The licensed product does not need to be mixed with anything before use. If you have encountered instructions on how to mix tirzepatide with bacteriostatic water or another solvent, those refer to unlicensed, compounded preparations that are not authorised for use in the UK. Tirzepatide in the UK is dispensed as a ready-to-use pen, and the NHS tirzepatide medicines page confirms this presentation. A prescription from a GPhC-registered Independent Prescriber is required before any supply; a prescriber decides suitability based on your full clinical picture, not BMI alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The MHRA-authorised form of tirzepatide in the UK is Mounjaro, a once-weekly subcutaneous injection supplied in a pre-filled KwikPen. Each pen contains four pre-measured doses at a single strength, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg. The solution inside is clear and colourless to slightly yellow. You dial the pen, pinch the skin at the injection site (abdomen, thigh or upper arm), press the button and the dose delivers. There is nothing to draw up, nothing to weigh, nothing to dissolve.
This matters because a common misconception online is that tirzepatide always comes as a lyophilised powder that patients mix themselves. It does not, at least not in its licensed UK form. The Mounjaro KwikPen was designed partly to remove that complexity and the errors that come with it. Treatment starts at 2.5 mg, a dose chosen to let the body adjust rather than achieve immediate weight loss, before the prescriber guides titration upward. Dosing schedules are set by the prescriber; the Patient Information Leaflet covers the precise steps for each injection.
Before use, always check the solution is clear and that the pen has been stored correctly. The Mounjaro SmPC, available on the electronic Medicines Compendium, sets out the exact storage window at room temperature, refrigeration at 2–8°C is the default. Always refer to the leaflet supplied with your pen; a summary on a webpage is no substitute for the authoritative document.
Queries about how to mix tirzepatide almost always refer to compounded tirzepatide: a powdered or crystalline form of the active ingredient, sold by unregulated online sellers, that the buyer is expected to dissolve in bacteriostatic water at home before injecting. This process is described in detail on various forums and social media channels, including guides on how to mix tirzepatide with water and on how to mix bac water and tirzepatide, none of which reflect the licensed UK supply chain. It is also entirely outside the licensed UK supply chain.
The MHRA has been unambiguous about this. Following large-scale enforcement action in 2025 (including the raid of an unlicensed site producing counterfeit tirzepatide pens in Northampton) the regulator reiterated that GLP-1 medicines for weight loss sourced outside the regulated supply chain carry serious safety risks. Concentration errors when reconstituting powder, contamination from non-sterile water or vials, and the simple absence of any clinical oversight are among the documented harms. The MHRA's Yellow Card scheme exists precisely so patients can report adverse events and suspect sellers, use it if you encounter a product that does not come in a pre-filled, MHRA-authorised pen.
If you want to understand the difference between the genuine product and what circulates outside it, the reconstitution context page covers this distinction thoroughly. The short version: licensed Mounjaro requires no mixing at all.
The only legal route to tirzepatide in the UK is a prescription following a clinical assessment. A qualified prescriber reviews your medical history, current medications, BMI and any weight-related conditions before deciding whether it is appropriate. That assessment is not a formality; it exists because tirzepatide is a potent medicine with a real side-effect profile and genuine contraindications.
The NICE technology appraisal for tirzepatide (TA1026) sets out the clinical criteria used to guide prescribing decisions, including BMI thresholds and qualifying comorbidities. Private clinics and online pharmacies that operate within the licensed framework source their pens through Eli Lilly's authorised UK supply chain. You can verify any online pharmacy on the GPhC pharmacy register before handing over personal details or payment.
At nume (sorry, at our pharmacy) every consultation is reviewed the same day by a real, named prescriber. Not software. If you are clinically suitable, treatment is dispatched the same day for free next-working-day delivery by DPD, tracked, in plain packaging. For anyone currently thinking about starting tirzepatide or switching from another route, the weight-loss treatment overview sets out the full picture. And if the cost of private treatment is a question on your mind, the private Mounjaro pricing context explains what a legitimate price actually covers.
Speak to our prescribers if you have questions about eligibility, your current dose, or anything in the process. A free consultation is the starting point, no commitment, just a proper clinical conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.